Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from HeraMED Ltd. ( (AU:HMD) ) is now available.
HeraMED Limited has announced the scheduling of its Annual General Meeting (AGM) for 29 May 2025, to be held at BDO Offices in Docklands, VIC. The company emphasizes the importance of shareholder participation, encouraging votes to be submitted by proxy if attendance is not possible. This meeting is significant for stakeholders as it will address resolutions affecting shareholding, with all resolutions to be decided by a poll.
More about HeraMED Ltd.
HeraMED Limited is an innovative medical data and technology company that is pioneering the digital transformation of maternity care. The company offers a hybrid maternity care platform that integrates hardware and software to enhance the prenatal and postpartum experience. Their key products include the HeraBEAT, an in-home fetal and maternal heart rate monitor, and HeraCARE, a comprehensive maternal health ecosystem designed to provide better care at lower costs while ensuring engagement and support for expectant mothers.
Technical Sentiment Signal: Buy
Current Market Cap: €7.88M
See more insights into HMD stock on TipRanks’ Stock Analysis page.